Grown Rogue International GRUSF
OTC GRUSF
$0.46 +0.00 (+0.66%)
At close: Aug 19, 2026 · 7:39 PM UTC

Grown Rogue International (GRUSF) Income from Non-Controlling Interests (2013 - 2026)

Grown Rogue International (GRUSF) posted quarterly Income from Non-Controlling Interests of -$488826.0 for Q1 2026, down 239.26% year-over-year from $351029.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$321.7 billion in Q4 2025.

Grown Rogue International (GRUSF) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends

Grown Rogue International's Income from Non-Controlling Interests history runs 11 years deep, the most recent figure standing at -$488826.0 for Q1 2026.

  • In Q1 2026, Income from Non-Controlling Interests fell 239.26% year-over-year to -$488826.0; the TTM figure through Mar 2026 stood at -$182.1 billion (down 29.91% YoY), while the FY2025 annual figure was -$1.5 million, down 8499.04% from the prior year.
  • Income from Non-Controlling Interests for Q1 2026 stood at -$488826.0, up from -$321.7 billion in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $139.6 billion in Q3 2025, with the low at -$321.7 billion in Q4 2025.
  • The 5-year median for Income from Non-Controlling Interests is $30728.0 (2024), against an average of -$21.5 billion.
  • The sharpest annual moves came in 2022 and 2024: Income from Non-Controlling Interests surged 11432.01% in 2022, then tumbled 915246434.11% in 2024.
  • Grown Rogue International's Income from Non-Controlling Interests stood at $564607.0 in 2022, then plunged by 94.76% to $29607.0 in 2023, then sank by 915246434.11% to -$271.0 billion in 2024, then fell by 18.72% to -$321.7 billion in 2025, then soared by 100.0% to -$488826.0 in 2026.
  • Business Quant data shows GRUSF's Income from Non-Controlling Interests at -$488826.0 in Q1 2026, -$321.7 billion in Q4 2025, and $139.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 43.30 Bn 39.65 Bn 2.15 Bn -
3 Zoetis 31.45 Bn 29.77 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn 376,434.15
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn -
8 Elanco Animal Health 11.70 Bn 11.17 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Grown Rogue International 109.32 Mn 97.78 Mn 5.37 Mn -211,812.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -211,812.00
Mar 31, 2026 -488,826.00
Dec 31, 2025 -321.70 Bn
Sep 30, 2025 139.57 Bn
Jun 30, 2025 99,131.00
Mar 31, 2025 -144,088.00
Dec 31, 2024 -270.98 Bn
Sep 30, 2024 130.78 Bn
Jun 30, 2024 80,039.42
Mar 31, 2024 30,728.00
Dec 31, 2023 29,607.00
Oct 31, 2023 210,129.00
Jul 31, 2023 119,093.00
Apr 30, 2023 -867.00
Jan 31, 2023 -339,408.00
Jan 31, 2022 564,607.00
Oct 31, 2021 1.12 Mn
Jul 31, 2021 283,126.00
Apr 30, 2021 -15,306.00
Jan 31, 2021 4,896.00